Filing Details
- Accession Number:
- 0001683168-19-001919
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-06-17 16:20:12
- Reporting Period:
- 2019-06-05
- Accepted Time:
- 2019-06-17 16:20:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1622879 | Medicine Man Technologies Inc. | MDCL | Services-Management Consulting Services (8742) | 465289499 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1654539 | Justin Dye | C/O Medicine Man Technologies, Inc. 4880 Havana Street, Suite 201 Denver CO 90239 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-06-05 | 1,500,000 | $2.00 | 1,500,000 | No | 4 | P | Indirect | See footnote 1 |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See footnote 1 |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Option to purchase common stock | Acquisiton | 2019-06-05 | 300,000 | $0.00 | 300,000 | $3.72 |
Common Stock | Warrant to purchase common stock | Acquisiton | 2019-06-05 | 1,500,000 | $0.00 | 1,500,000 | $3.50 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
300,000 | 2019-06-05 | 2022-06-05 | No | 4 | A | Direct |
1,500,000 | 2019-06-05 | 2022-06-05 | No | 4 | P | Indirect |
Footnotes
- On June 5, 2019, Medicine Man Technologies, Inc. (the "Company") entered into a securities purchase agreement (the "Purchase Agreement") with Dye Capital Cann Holdings, LLC (the "Investor"). The Reporting Person has voting and investment control of the securities owned by the Investor and disclaims beneficial ownership of the securities for purposes of Section 16 except to the extent of the Reporting Person's pecuniary interest therein. Pursuant to the Purchase Agreement, the Investor purchased, in a private placement 1,500,000 shares of the Company's common stock, par value $0.001 per share (the "Common Stock") at a price of $2.00 per share and warrants (the "Warrants") to purchase 1,500,000 shares of Common Stock. The Warrants are for a term of three years and are exercisable at a price of $3.50.
- The Option vests in 1/2 increments on the one (1) and two (2) year anniversaries of the date of grant.